The Journal of Experimental Medicine
CSHL Meetings & Courses
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 4 June 2001.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirchgessner, H.
Right arrow Articles by Schraven, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirchgessner, H.
Right arrow Articles by Schraven, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/6/1269/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 11, June 4, 2001 1269-1284


Original Article

The Transmembrane Adaptor Protein TRIM Regulates T Cell Receptor (TCR) Expression and TCR-mediated Signaling via an Association with the TCR {zeta} Chain

Henning Kirchgessnera, Jes Dietrichb, Jeanette Scherera, Pia Isomäkic, Vladimir Korinekd, Ivan Hilgertd, Eddy Bruynsa, Albrecht Leoa, Andrew P. Copec, and Burkhart Schravena,e
a Institute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
b Institute of Medical Microbiology and Immunology, University of Copenhagen, DK-2200 Copenhagen, Denmark
c Kennedy Institute of Rheumatology Division, Imperial College School of Medicine,
d Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 14220 Praque, Czech Republic
e Institute for Immunology, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany

Correspondence to: Burkhart Schraven, Institute for Immunology, Otto-von-Guericke-University Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany. Tel:391-67-15800 Fax:391-67-15852 E-mail:burkhart.schraven{at}medizin.uni-magdeburg.de.

T cell receptor (TCR)-interacting molecule (TRIM) is a recently identified transmembrane adaptor protein, which is exclusively expressed in T cells. Here we demonstrate that in mature T cells, TRIM preferentially interacts with the TCR via the TCR-{zeta} chains and to a lesser extent via the CD3-{epsilon}/{gamma} heterodimer. Transient or stable overexpression of TRIM in Jurkat T cells results in enhancement of TCR expression on the cell surface and elevated induction of Ca2+ mobilization after T cell activation. TRIM-mediated upregulation of TCR expression results from inhibition of spontaneous TCR internalization and stabilization of TCR complexes on the cell surface. Collectively, our data identify TRIM as a novel integral component of the TCR complex and suggest that one function of TRIM might be to modulate the strength of signals transduced through the TCR through regulation of TCR expression on the cell surface.

Key Words: T lymphocytes, signal transduction, T cell receptor complex, {zeta} chains, transmembrane adaptor proteins


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS